This report is based on proceedings from the Exposure Assessment Tools for
Hypersensitivity Pneumonitis (HP) Workshop, sponsored by the American Thoracic Society …

Background The purpose of this analysis is to provide evidence-based and consensus-
derived guidance for clinicians to improve individual diagnostic decision-making for …

Background Chronic hypersensitivity pneumonitis (CHP) is an immune-mediated interstitial
lung disease (ILD) caused by inhalational exposure to environmental antigens, resulting in …

Hypersensitivity pneumonitis is an immune-mediated inflammatory lung disease
characterised by the inhalation of environmental antigens leading to acute and chronic lung …

Hypersensitivity pneumonitis (HP) develops after inhalation of many different environmental
antigens, causing variable clinical symptoms that often make diagnosis uncertain. The …

Hypersensitivity pneumonitis is a dynamic and heterogeneous group of diseases resulting
from inhalational exposure to a variety of organic and inorganic dusts. In the United States, it …

Hypersensitivity pneumonitis (HP) is a pulmonary disease with symptoms of dyspnea and
cough resulting from the inhalation of an antigen to which the patient has been previously …

The aim of this document was to provide a critical review of the current knowledge on
hypersensitivity pneumonitis caused by the occupational environment and to propose …

Hypersensitivity pneumonitis (HP) is a group of immunologically mediated lung diseases
caused by the inhalation of environmental agents in susceptible individuals. Most HP …

Hypersensitivity pneumonitis (extrinsic allergic alveolitis) caused by inhaled allergens can
progress to disabling or even fatal end-stage lung disease. The only truly effective treatment …